DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Melevodopa

Melevodopa

  • Ubocom I' Iiiiiiiiiiiiiiiiiiiiiiii I'iii

    Ubocom I' Iiiiiiiiiiiiiiiiiiiiiiii I'iii

  • I Regulations

    I Regulations

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A

    New Information of Dopaminergic Agents Based on Quantum Chemistry Calculations Guillermo Goode‑Romero1*, Ulrika Winnberg2, Laura Domínguez1, Ilich A

  • Antiparkinsonianos

    Antiparkinsonianos

  • (12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2010/0184806 A1 Barlow Et Al

  • List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify

    List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify

  • WO 2014/006004 Al 9 January 2014 (09.01.2014) P O P C T

    WO 2014/006004 Al 9 January 2014 (09.01.2014) P O P C T

  • Design and Evaluation of Levodopa Methyl Ester Intranasal Delivery Systems

    Design and Evaluation of Levodopa Methyl Ester Intranasal Delivery Systems

  • Continuous Dopaminergic Stimulation in a Patient Treated with Daytime

    Continuous Dopaminergic Stimulation in a Patient Treated with Daytime

  • WO 2016/036308 Al 10 March 2016 (10.03.2016) P O P C T

    WO 2016/036308 Al 10 March 2016 (10.03.2016) P O P C T

  • Overview of Parkinson's Disease Treatment Options

    Overview of Parkinson's Disease Treatment Options

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Levodopa May Affect Cortical Excitability in Parkinson's Disease

    Levodopa May Affect Cortical Excitability in Parkinson's Disease

  • Creativity Assessment in Subjects with Tourette Syndrome Vs. Patients with Parkinson’S Disease: a Preliminary Study

    Creativity Assessment in Subjects with Tourette Syndrome Vs. Patients with Parkinson’S Disease: a Preliminary Study

  • L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa Versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson’S Disease: a Randomised Study

    L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa Versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson’S Disease: a Randomised Study

  • Pharmaabkommen A1 E

    Pharmaabkommen A1 E

  • Customs Tariff - Schedule Xxi - 1

    Customs Tariff - Schedule Xxi - 1

Top View
  • (12) United States Patent (10) Patent No.: US 9,358,295 B2 Tygesen Et Al
  • University of Groningen Synthesis and Evaluation of Dopaminergic
  • Intrajejunal Levodopa Infusion in Advanced Parkinson's Disease
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0329780 A1 Thormann Et Al
  • Tepzz 5 58¥Zb T
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Development of a Hydrophobicity-Controlled Delivery System Containing Levodopa Methyl Ester Hydrochloride Loaded Into a Mesoporous Silica
  • WO 2018/206820 Al 15 November 2018 (15.11.2018) W ! P O P C T
  • Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
  • European Parkinson's Disease Recommendations
  • Pharmaceutical Compositions Resistant to Abuse


© 2024 Docslib.org    Feedback